Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

V2 Capital snags big investment, looks to expand product pipeline

Thursday, January 23, 2014

Bailey McCann, Opalesque New York:

V2 Capital's Hedged Equity Fund is on track for a strong fourth year with the announcement of a new $200m investment. The investment comes from a Fortune 500 insurance company and the firm hopes that it will be the first of many such relationships in the future. V2 Hedged Equity Strategy,combines a long portfolio of U.S. stocks with a custom tailored short portfolio of index options.

The fund has been targeted to the qualified purchaser market since its inception, and has steadily been building assets. Opalesque spoke with V2 CIO, Victor Viner when the fund hit its three year milestone early last year. Since then, the fund has been recommended as both core equities exposure and long/short equities exposure within the universe of qualified purchasers. The latest allocation represents an entirely new client relationship. One of the long time investors in the fund has also been Ken Langone – the Co-Founder of Home Depot.

Viner explains that the V2 structure - which does not charge a performance fee, was created on the idea that the industry is moving away from the 2/20 fee structure.

"I believe the industry is moving toward management fees only. We've been out in front on the issue, and I think we're seeing the results of that." Viner tells Opalesque. "The latest allocation further validates our bel......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its